Jaynes-Gibbs Entropic Convex Duals and Orthogonal Polynomials

por Le Blanc, Richard
Publicado 2022

Young Myeloma Patients: A Systematic Review of Manifestations and Outcomes

por Tanguay, Mégane, Dagenais, Christophe, LeBlanc, Richard, Ahmad, Imran, Claveau, Jean-Sébastien, Roy, Jean
Publicado 2023

Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus

por Reece, Donna, Kouroukis, C. Tom, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Ashkenas, John
Publicado 2012

Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma

por Giguère, Amélie, Raymond-Bouchard, Isabelle, Collin, Vanessa, Claveau, Jean-Sébastien, Hébert, Josée, LeBlanc, Richard
Publicado 2023

Early free light chain reduction following treatment initiation predicts favorable outcome in intact immunoglobulin myeloma

por Claveau, Jean-Sébastien, Savary Bélanger, Sophie, Ahmad, Imran, Delisle, Jean-Sébastien, De Guire, Vincent, Roy, Jean, LeBlanc, Richard
Publicado 2022

Retrospective Study of High Hemoglobin Levels in 56 Young Adults

por Desnoyers, Alexandra, Pavic, Michel, Houle, Paul-Michel, Castilloux, Jean-Francois, Beauregard, Patrice, Delisle, Line, Le Blanc, Richard, Dufresne, Jean, Boisjoly, Josie-Anne, Ethier, Vincent
Publicado 2018

Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis

por Capra, Marcelo, Martin, Thomas, Moreau, Philippe, Baker, Ross, Pour, Ludek, Min, Chang-Ki, Leleu, Xavier, Mohty, Mohamad, Segura, Marta Reinoso, Turgut, Mehmet, LeBlanc, Richard, Risse, Marie-Laure, Malinge, Laure, Schwab, Sandrine, Dimopoulos, Meletios
Publicado 2021

Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial

por Dimopoulos, Meletios A., Dytfeld, Dominik, Grosicki, Sebastian, Moreau, Philippe, Takezako, Naoki, Hori, Mitsuo, Leleu, Xavier, LeBlanc, Richard, Suzuki, Kenshi, Raab, Marc S., Richardson, Paul G., Popa McKiver, Mihaela, Jou, Ying-Ming, Yao, David, Das, Prianka, San-Miguel, Jesús
Publicado 2023

Sequential Use of Carfilzomib and Pomalidomide in Relapsed Multiple Myeloma: A Report from the Canadian Myeloma Research Group (CMRG) Database

por McCurdy, Arleigh, Venner, Christopher P., Masih-Khan, Esther, Louzada, Martha, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Jimenez-Zepeda, Victor H., Kotb, Rami, Kardjadj, Moustafa, Mian, Hira, White, Darrell, Stakiw, Julie, Aslam, Muhammad, Reiman, Anthony, Gul, Engin, Reece, Donna
Publicado 2022

Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database

por Mian, Hira, LeBlanc, Richard, Louzada, Martha, Masih‐Khan, Esther, McCurdy, Arleigh, Venner, Christopher P., Stakiw, Julie, Kardjadj, Moustafa, Jimenez‐Zepeda, Victor H., Sebag, Michael, White, Darrell, Aslam, Muhammad, Song, Kevin, Reiman, Anthony, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

The survival impact of maintenance lenalidomide: an analysis of real-world data from the Canadian Myeloma Research Group national database

por Cherniawsky, Hannah M., Kukreti, Vishal, Reece, Donna, Masih-Khan, Esther, McCurdy, Arleigh, Jimenez-Zepeda, Victor H., Sebag, Michael, Song, Kevin, White, Darrell, Stakiw, Julie, LeBlanc, Richard, Reiman, Anthony, Aslam, Muhammad, Louzada, Martha, Kotb, Rami, Gul, Engin, Atenafu, Eshetu, Venner, Christopher P.
Publicado 2020

Carfilzomib usage patterns and outcomes in patients with relapsed multiple myeloma: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) Database

por McCurdy, Arleigh, Louzada, Martha, Venner, Christopher P., Visram, Alissa, Masih‐Khan, Esther, Kardjadj, Moustafa, Jimenez‐Zepeda, Victor H., LeBlanc, Richard, Sebag, Michael, Song, Kevin, White, Darrell, Mian, Hira, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

por McCurdy, Arleigh, Mian, Hira, LeBlanc, Richard, Jimenez-Zepeda, Victor H., Su, Jiandong, Masih-Khan, Esther, Visram, Alissa, Louzada, Martha, Song, Kevin, White, Darrell, Sebag, Michael, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Bergstrom, Debra, Kotb, Rami, Kaedbey, Rayan, Gul, Engin, Reece, Donna, Venner, Christopher P.
Publicado 2023

Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

por McCurdy, Arleigh, Mian, Hira, LeBlanc, Richard, Jimenez-Zepeda, Victor H., Su, Jiandong, Masih-Khan, Esther, Visram, Alissa, Louzada, Martha, Song, Kevin, White, Darrell, Sebag, Michael, Stakiw, Julie, Reiman, Anthony, Aslam, Muhammad, Bergstrom, Debra, Kotb, Rami, Kaedbey, Rayan, Gul, Engin, Reece, Donna, Venner, Christopher P.
Publicado 2023

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

por Mian, Hira, Eisfeld, Christine, Venner, Christopher P., Masih-Khan, Esther, Kardjadj, Moustafa, Jimenez-Zepeda, Victor H., Khandanpour, Cyrus, Lenz, Georg, McCurdy, Arleigh, Sebag, Michael, Song, Kevin, LeBlanc, Richard, White, Darrell, Stakiw, Julie, Reiman, Anthony, Louzada, Martha, Aslam, Muhammad, Kotb, Rami, Gul, Engin, Reece, Donna
Publicado 2022

Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database

por Côté, Julie, LeBlanc, Richard, Mian, Hira, Chu, Michael P., McCurdy, Arleigh, Masih-Khan, Esther, Su, Jiandong, Jimenez-Zepeda, Victor H., Song, Kevin, Louzada, Martha, White, Darrell, Sebag, Michael, Reiman, Anthony, Stakiw, Julie, Kotb, Rami, Bergstrom, Debra, Aslam, Muhammad, Kaedbey, Rayan, Venner, Christopher P., Gul, Engin, Reece, Donna
Publicado 2023

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma: A phase 1/2 study

por Lesokhin, Alexander, LeBlanc, Richard, Dimopoulos, Meletios A., Capra, Marcelo, Carlo‐Stella, Carmelo, Karlin, Lionel, Castilloux, Jean‐Francois, Forsberg, Peter, Parmar, Gurdeep, Tosikyan, Axel, Pour, Ludek, Ribrag, Vincent, Ribolla, Rossella, Abdallah, Al‐Ola, Le Roux, Nadia, Dong, Liyan, van de Velde, Helgi, Mayrargue, Laurent, Lépine, Lucie, Macé, Sandrine, Moreau, Philippe
Publicado 2023

Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma

por Gasparetto, Cristina, Lentzsch, Suzanne, Schiller, Gary, Callander, Natalie, Tuchman, Sascha, Chen, Christine, White, Darrell, Kotb, Rami, Sutherland, Heather, Sebag, Michael, Baljevic, Muhamed, Bensinger, William, LeBlanc, Richard, Venner, Chris, Bahlis, Nizar, Rossi, Adriana, Biran, Noa, Sheehan, Heidi, Saint‐Martin, Jean‐Richard, Van Domelen, Dane, Kai, Kazuharu, Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Lipe, Brea
Publicado 2020

Randomized, placebo‐controlled, phase 3 study of perifosine combined with bortezomib and dexamethasone in patients with relapsed, refractory multiple myeloma previously treated wit...

por Richardson, Paul G., Nagler, Arnon, Ben‐Yehuda, Dina, Badros, Ashraf, Hari, Parameswaran N., Hajek, Roman, Spicka, Ivan, Kaya, Hakan, LeBlanc, Richard, Yoon, Sung‐Soo, Kim, Kihyun, Martinez‐Lopez, Joaquin, Mittelman, Moshe, Shpilberg, Ofer, Blake, Paul, Hideshima, Teru, Colson, Kathleen, Laubach, Jacob P., Ghobrial, Irene M., Leiba, Merav, Gatt, Moshe E., Sportelli, Peter, Chen, Michael, Anderson, Kenneth C.
Publicado 2020

Selinexor‐based regimens in patients with multiple myeloma after prior anti‐B‐cell maturation antigen treatment

por Baljevic, Muhamed, Gasparetto, Cristina, Schiller, Gary J., Tuchman, Sascha A., Callander, Natalie S., Lentzsch, Suzanne, Monge, Jorge, Kotb, Rami, Bahlis, Nizar J., White, Darrell, Chen, Christine I., Sutherland, Heather J., Madan, Sumit, LeBlanc, Richard, Sebag, Michael, Venner, Christopher P., Bensinger, William I., Biran, Noa, DeCastro, Andrew, Van Domelen, Dane R., Zhang, Chris, Shah, Jatin J., Shacham, Sharon, Kauffman, Michael G., Bentur, Ohad S., Lipe, Brea
Publicado 2022